158 related articles for article (PubMed ID: 12566458)
1. The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death.
Chen MC; Hwang MJ; Chou YC; Chen WH; Cheng G; Nakano H; Luh TY; Mai SC; Hsieh SL
J Biol Chem; 2003 May; 278(18):16073-81. PubMed ID: 12566458
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3.
You RI; Chen MC; Wang HW; Chou YC; Lin CH; Hsieh SL
Cancer Res; 2006 Mar; 66(6):3051-61. PubMed ID: 16540654
[TBL] [Abstract][Full Text] [Related]
3. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
Kim YS; Nedospasov SA; Liu ZG
Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
5. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells.
Stopfer P; Männel DN; Hehlgans T
J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124
[TBL] [Abstract][Full Text] [Related]
6. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.
Rooney IA; Butrovich KD; Glass AA; Borboroglu S; Benedict CA; Whitbeck JC; Cohen GH; Eisenberg RJ; Ware CF
J Biol Chem; 2000 May; 275(19):14307-15. PubMed ID: 10799510
[TBL] [Abstract][Full Text] [Related]
7. LIGHT sensitizes IFN-gamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways.
Zhang MC; Liu HP; Demchik LL; Zhai YF; Yang DJ
Cell Res; 2004 Apr; 14(2):117-24. PubMed ID: 15115612
[TBL] [Abstract][Full Text] [Related]
8. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis.
Matsui H; Hikichi Y; Tsuji I; Yamada T; Shintani Y
J Biol Chem; 2002 Dec; 277(51):50054-61. PubMed ID: 12393901
[TBL] [Abstract][Full Text] [Related]
9. The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization.
Liu HP; Chung PJ; Liang CL; Chang YS
Cell Signal; 2011 Jan; 23(1):80-8. PubMed ID: 20732415
[TBL] [Abstract][Full Text] [Related]
10. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion.
Wang YG; Kim KD; Wang J; Yu P; Fu YX
J Immunol; 2005 Nov; 175(10):6997-7002. PubMed ID: 16272360
[TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation.
Chang YH; Hsieh SL; Chen MC; Lin WW
Exp Cell Res; 2002 Aug; 278(2):166-74. PubMed ID: 12169272
[TBL] [Abstract][Full Text] [Related]
12. Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways.
Force WR; Glass AA; Benedict CA; Cheung TC; Lama J; Ware CF
J Biol Chem; 2000 Apr; 275(15):11121-9. PubMed ID: 10753918
[TBL] [Abstract][Full Text] [Related]
13. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
14. LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
PLoS One; 2016; 11(11):e0166589. PubMed ID: 27835685
[TBL] [Abstract][Full Text] [Related]
15. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.
Bechill J; Muller WJ
Mol Immunol; 2014 Nov; 62(1):96-103. PubMed ID: 24980868
[TBL] [Abstract][Full Text] [Related]
16. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
[TBL] [Abstract][Full Text] [Related]
18. Differential cellular expression of LIGHT and its receptors in early gestation human placentas.
Gill RM; Coleman NM; Hunt JS
J Reprod Immunol; 2007 Jun; 74(1-2):1-6. PubMed ID: 17010447
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.
Cheung TC; Coppieters K; Sanjo H; Oborne LM; Norris PS; Coddington A; Granger SW; Elewaut D; Ware CF
J Immunol; 2010 Aug; 185(3):1949-58. PubMed ID: 20592286
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the lymphotoxin beta receptor to liver regeneration.
Anders RA; Subudhi SK; Wang J; Pfeffer K; Fu YX
J Immunol; 2005 Jul; 175(2):1295-300. PubMed ID: 16002734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
